ENDOCHOICE HOLDINGS, INC. (GI) financial statements (2021 and earlier)
Company profile
Business Address |
11810 WILLS ROAD ALPHARETTA, GA 30009 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
SIC | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
9/30/2016 Q3 | 6/30/2016 Q2 | 3/31/2016 Q1 | 12/31/2015 Q4 | 9/30/2015 Q3 | 6/30/2015 Q2 | |||
---|---|---|---|---|---|---|---|---|
ASSETS | ||||||||
Current Assets | ||||||||
Cash, cash equivalents, and short-term investments | 44 | 57 | 65 | 68 | 74 | 118 | ||
Cash and cash equivalents | 15 | 14 | 27 | 34 | 48 | 118 | ||
Short-term investments | 29 | 42 | 38 | 34 | 26 | |||
Receivables | 10 | 11 | 9 | 10 | 8 | 8 | ||
Inventory, net of allowances, customer advances and progress billings | 16 | 16 | 17 | 17 | 16 | 12 | ||
Inventory | 16 | 16 | 17 | 17 | 16 | 12 | ||
Deferred tax assets | 0 | 0 | ||||||
Other undisclosed current assets | 4 | 3 | 3 | 3 | 4 | 3 | ||
Total current assets: | 74 | 87 | 93 | 98 | 102 | 142 | ||
Noncurrent Assets | ||||||||
Property, plant and equipment | 13 | 13 | 12 | 12 | 9 | 8 | ||
Long-term investments and receivables | 6 | 20 | 29 | |||||
Long-term investments | 6 | 20 | 29 | |||||
Intangible assets, net (including goodwill) | 21 | 20 | 34 | 34 | 34 | 36 | ||
Goodwill | 21 | 20 | 21 | 20 | 20 | 21 | ||
Intangible assets, net (excluding goodwill) | 14 | 14 | 14 | 16 | ||||
Deferred tax assets, net | 0 | 0 | ||||||
Other undisclosed noncurrent assets | 1 | 1 | 1 | 1 | 1 | 1 | ||
Total noncurrent assets: | 35 | 34 | 54 | 66 | 73 | 45 | ||
TOTAL ASSETS: | 109 | 121 | 147 | 164 | 175 | 188 | ||
LIABILITIES AND EQUITY | ||||||||
Liabilities | ||||||||
Current Liabilities | ||||||||
Accounts payable and accrued liabilities | 16 | 14 | 14 | 17 | 16 | 10 | ||
Accounts payable | 6 | 6 | 6 | 8 | 7 | 5 | ||
Accrued liabilities | 4 | 3 | 4 | 4 | 4 | 5 | ||
Employee-related liabilities | 6 | 5 | 4 | 5 | 5 | |||
Taxes payable | 0 | 0 | ||||||
Deferred revenue and credits | 1 | 1 | 1 | 1 | 1 | 1 | ||
Other undisclosed current liabilities | 2 | 0 | 0 | 0 | 0 | 6 | ||
Total current liabilities: | 19 | 15 | 15 | 19 | 17 | 17 | ||
Noncurrent Liabilities | ||||||||
Long-term debt and lease obligation | 43 | 43 | 43 | 43 | 43 | 43 | ||
Long-term debt, excluding current maturities | 43 | 43 | 43 | 43 | 43 | 43 | ||
Liabilities, other than long-term debt | 2 | 2 | 4 | 4 | 5 | 5 | ||
Deferred revenue and credits | 1 | 1 | 1 | 1 | 0 | 0 | ||
Deferred tax liabilities, net | 3 | 2 | 4 | 4 | ||||
Other liabilities | 1 | 1 | 1 | 1 | 1 | 1 | ||
Total noncurrent liabilities: | 45 | 44 | 47 | 47 | 48 | 48 | ||
Total liabilities: | 63 | 60 | 62 | 65 | 65 | 65 | ||
Stockholders' equity | ||||||||
Stockholders' equity attributable to parent | 46 | 61 | 85 | 99 | 110 | 123 | ||
Common stock | 0 | 0 | 0 | 0 | 0 | 0 | ||
Additional paid in capital | 262 | 260 | 259 | 257 | 256 | 256 | ||
Accumulated other comprehensive loss | (0) | (1) | (0) | (2) | (2) | (1) | ||
Accumulated deficit | (216) | (198) | (174) | (157) | (144) | (132) | ||
Total stockholders' equity: | 46 | 61 | 85 | 99 | 110 | 123 | ||
TOTAL LIABILITIES AND EQUITY: | 109 | 121 | 147 | 164 | 175 | 188 |
Income statement (P&L) ($ in millions)
9/30/2016 Q3 | 6/30/2016 Q2 | 3/31/2016 Q1 | 12/31/2015 Q4 | 9/30/2015 Q3 | 6/30/2015 Q2 | ||
---|---|---|---|---|---|---|---|
Revenues (Revenue, Net) | 19 | 19 | 18 | 19 | 18 | 19 | |
Cost of revenue (Cost of Goods and Services Sold) | (13) | (13) | (14) | (13) | (12) | (12) | |
Gross profit: | 6 | 6 | 5 | 5 | 6 | 7 | |
Operating expenses | (22) | (33) | (21) | (18) | (17) | (21) | |
Operating loss: | (16) | (27) | (16) | (13) | (10) | (15) | |
Nonoperating income (expense) | (0) | 0 | 0 | (1) | (1) | (4) | |
Foreign currency transaction gain, before tax | 1 | ||||||
Other nonoperating income (expense) | (1) | (1) | 0 | (2) | (1) | (4) | |
Interest and debt expense | (1) | (1) | (1) | 4 | (1) | (4) | |
Loss from continuing operations before equity method investments, income taxes: | (17) | (28) | (17) | (9) | (12) | (23) | |
Other undisclosed income (loss) from continuing operations before income taxes | (5) | 1 | 4 | ||||
Loss from continuing operations before income taxes: | (17) | (28) | (17) | (14) | (11) | (19) | |
Income tax expense (benefit) | (0) | 3 | 0 | 1 | (0) | (0) | |
Net loss available to common stockholders, diluted: | (17) | (25) | (17) | (13) | (12) | (19) |
Comprehensive Income ($ in millions)
9/30/2016 Q3 | 6/30/2016 Q2 | 3/31/2016 Q1 | 12/31/2015 Q4 | 9/30/2015 Q3 | 6/30/2015 Q2 | ||
---|---|---|---|---|---|---|---|
Net loss: | (17) | (25) | (17) | (13) | (12) | (19) | |
Other comprehensive income (loss) | 1 | (1) | 1 | (1) | 2 | ||
Comprehensive loss: | (17) | (26) | (17) | (12) | (13) | (18) | |
Other undisclosed comprehensive income, net of tax, attributable to parent | 1 | ||||||
Comprehensive loss, net of tax, attributable to parent: | (17) | (26) | (16) | (12) | (13) | (18) |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.